Rodriguez Javier
SEC CIK 1415548 · EDGAR
BoughtSold
Most active insiders at DVA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | BERKSHIRE HATHAWAY INC | 10% | — | $273.73M |
| 2 | BUFFETT WARREN E | 10% | — | $199.95M |
| 3 | Rodriguez Javier | CEO, Dir | — | $14.53M |
| 4 | ACKERMAN JOEL | CFO, Treasuer | — | $9.89M |
| 5 | Maughan David Paul | COO, DKC | — | $4.09M |
| 6 | HEARTY JAMES O | CCO | — | $3.29M |
| 7 | Waters Kathleen Alyce | Chief Legal, Pub. Affairs Off | — | $3.21M |
| 8 | Pullin Dennis W | Dir | — | — |
| 9 | Moore Gregory J. | Dir | — | — |
| 10 | Hollar Jason M. | Dir | — | — |
Transactions 38
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-06-17 18:09 | 2026-06-15+ | DVA | DaVita | Rodriguez Javier | CEO, Dir | S - Sale | $209.38 | -69.4K | 840.4K | -8% | -$14.53M |
| D | 2026-05-04 16:25 | 2026-04-30 | GILD | Gilead Sciences | Rodriguez Javier | Dir | A - Grant | $0.00 | +1,146 | 13.4K | +9% | $0 |
| D | 2026-03-17 | 2026-03-15 | DVA | DaVita | Rodriguez Javier | CEO, Dir | A - Grant | $0.00 | +20.9K | 909.8K | +2% | $0 |
| 2025-11-17 | 2025-11-15 | DVA | DaVita | Rodriguez Javier | CEO, Dir | F - Tax | $121.55 | -5,165 | 888.9K | -0.6% | -$627.8K | |
| D | 2025-05-08 | 2025-05-07 | GILD | Gilead Sciences | Rodriguez Javier | Dir | A - Grant | $0.00 | +1,516 | 12.2K | +14% | $0 |
| D | 2025-03-18 | 2025-03-15 | DVA | DaVita | Rodriguez Javier | CEO, Dir | A - Grant | $0.00 | +18.8K | 894.1K | +2% | $0 |
| 2024-11-19 | 2024-11-15 | DVA | DaVita | Rodriguez Javier | CEO, Dir | A - Grant | $0.00 | +37.4K | 875.3K | +4% | $0 | |
| M | 2024-09-17 | 2024-09-13+ | DVA | DaVita | Rodriguez Javier | CEO, Dir | S - Sale | $164.69 | -59.9K | 887.8K | -6% | -$9.86M |
| M | 2024-08-28 | 2024-08-26+ | DVA | DaVita | Rodriguez Javier | CEO, Dir | S - Sale | $155.93 | -40.1K | 905.7K | -4% | -$6.26M |
| D | 2024-08-22 | 2024-08-20 | DVA | DaVita | Rodriguez Javier | CEO, Dir | F - Tax | $152.17 | -181.9K | 937.8K | -16% | -$27.68M |
| D | 2024-08-22 | 2024-08-20 | DVA | DaVita | Rodriguez Javier | CEO, Dir | D - Sale to Iss | $152.17 | -334.2K | 1.12M | -23% | -$50.85M |
| D | 2024-08-22 | 2024-08-20 | DVA | DaVita | Rodriguez Javier | CEO, Dir | M - OptEx | $67.80 | +750.0K | 1.45M | +107% | +$50.85M |
| D | 2024-05-09 | 2024-05-08 | GILD | Gilead Sciences | Rodriguez Javier | Dir | A - Grant | $0.00 | +2,310 | 10.7K | +28% | $0 |
| D | 2024-03-08 | 2024-03-06 | DVA | DaVita | Rodriguez Javier | CEO, Dir | F - Tax | $134.65 | -162.9K | 703.9K | -19% | -$21.94M |
| D | 2024-03-08 | 2024-03-06 | DVA | DaVita | Rodriguez Javier | CEO, Dir | D - Sale to Iss | $134.65 | -377.6K | 866.8K | -30% | -$50.85M |
| D | 2024-03-08 | 2024-03-06 | DVA | DaVita | Rodriguez Javier | CEO, Dir | M - OptEx | $67.80 | +750.0K | 1.24M | +152% | +$50.85M |
| DM | 2024-02-28 | 2024-02-26+ | DVA | DaVita | Rodriguez Javier | CEO, Dir | M - OptEx | $67.80 | +500.0K | 889.0K | +129% | +$33.90M |
| DM | 2024-02-28 | 2024-02-26+ | DVA | DaVita | Rodriguez Javier | CEO, Dir | D - Sale to Iss | $125.49 | -270.1K | 504.7K | -35% | -$33.90M |
| DM | 2024-02-28 | 2024-02-26+ | DVA | DaVita | Rodriguez Javier | CEO, Dir | S - Sale+OE | $126.18 | -75.0K | 481.3K | -13% | -$9.46M |
| DM | 2024-02-28 | 2024-02-26+ | DVA | DaVita | Rodriguez Javier | CEO, Dir | F - Tax | $125.50 | -99.4K | 494.5K | -17% | -$12.47M |
| D | 2023-12-18 | 2023-12-14 | DVA | DaVita | Rodriguez Javier | CEO, Dir | F - Tax | $108.80 | -82.7K | 439.0K | -16% | -$9.00M |
| D | 2023-12-18 | 2023-12-14 | DVA | DaVita | Rodriguez Javier | CEO, Dir | D - Sale to Iss | $108.80 | -311.6K | 521.7K | -37% | -$33.90M |
| D | 2023-12-18 | 2023-12-14 | DVA | DaVita | Rodriguez Javier | CEO, Dir | M - OptEx | $67.80 | +500.0K | 833.3K | +150% | +$33.90M |
| M | 2023-05-17 | 2023-05-15 | DVA | DaVita | Rodriguez Javier | CEO, Dir | F - Tax | $96.86 | -41.1K | 333.3K | -11% | -$3.98M |
| D | 2023-05-12 | 2023-05-10 | DVA | DaVita | Rodriguez Javier | CEO, Dir | D - Sale to Iss | $100.72 | -58.1K | 345.8K | -14% | -$5.85M |
| D | 2023-05-12 | 2023-05-10 | DVA | DaVita | Rodriguez Javier | CEO, Dir | F - Tax | $100.72 | -13.2K | 332.5K | -4% | -$1.33M |
| DM | 2023-05-12 | 2023-05-10 | DVA | DaVita | Rodriguez Javier | CEO, Dir | S - Sale+OE | $99.43 | -16.9K | 317.0K | -5% | -$1.68M |
| D | 2023-05-12 | 2023-05-10 | DVA | DaVita | Rodriguez Javier | CEO, Dir | A - Grant | $0.00 | +58.8K | 374.4K | +19% | $0 |
| D | 2023-05-12 | 2023-05-10 | DVA | DaVita | Rodriguez Javier | CEO, Dir | M - OptEx | $66.29 | +88.2K | 403.8K | +28% | +$5.85M |
| D | 2023-05-04 | 2023-05-03 | GILD | Gilead Sciences | Rodriguez Javier | Dir | A - Grant | $0.00 | +1,887 | 8,392 | +29% | $0 |
| D | 2022-06-07 | 2022-06-06 | DVA | DaVita | Rodriguez Javier | CEO, Dir | M - OptEx | $65.48 | +79.9K | 381.1K | +27% | +$5.23M |
| D | 2022-06-07 | 2022-06-06 | DVA | DaVita | Rodriguez Javier | CEO, Dir | D - Sale to Iss | $96.70 | -54.1K | 326.9K | -14% | -$5.23M |
| D | 2022-06-07 | 2022-06-06 | DVA | DaVita | Rodriguez Javier | CEO, Dir | F - Tax | $96.70 | -11.3K | 315.6K | -3% | -$1.10M |
| 2022-05-16 | 2022-05-12 | DVA | DaVita | Rodriguez Javier | CEO, Dir | A - Grant | $0.00 | +24.9K | 379.3K | +7% | $0 | |
| M | 2022-05-16 | 2022-05-15 | DVA | DaVita | Rodriguez Javier | CEO, Dir | F - Tax | $100.05 | -78.2K | 362.1K | -18% | -$7.82M |
| D | 2022-05-06 | 2022-05-05 | GILD | Gilead Sciences | Rodriguez Javier | Dir | A - Grant | $0.00 | +2,444 | 6,505 | +60% | $0 |
| D | 2022-05-03 | 2022-05-03 | GILD | Gilead Sciences | Rodriguez Javier | Dir | M - OptEx | — | +2,223 | 4,061 | +121% | — |
| M | 2022-04-26 | 2022-04-22 | DVA | DaVita | Rodriguez Javier | CEO, Dir | A - Grant | $0.00 | +109.5K | 354.4K | +45% | $0 |
Purchase Sale Sale after option exercise All abbreviations